India today logged 10,929 Active cases, lesser than Yesterday in number
The daily rise in new coronavirus infections has been below 20,000 for 29 straight days and less than 50,000 daily new cases have been reported for 132 days now.
According to the ministry; The daily positivity rate had been recorded at 1.35 per cent. For last 33 days It has been less than two per cent. The weekly positivity rate was also recorded at 1.27 per cent. It has been below two per cent for the last 42 days.
On Friday, India reported 11,903 new COVID-19 cases in the last 24 hours, which was 14% higher than the usual. The country also witnessed 311 Covid deaths in the day duration.
Equitable access to safe and effective vaccines is critical to ending the COVID-19 pandemic, so it is hugely encouraging to see so many vaccines proving and going into development. WHO is working tirelessly with partners to develop, manufacture and deploy safe and effective vaccines.
This week, the WHO granted Covaxin an Emergency Use Listing, which means the 'made-in-India' vaccine will finally be recognised by other countries and Indians who received the shot need not self-quarantine or face restrictions when travelling abroad.
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 107.92 crore.
The emergency use listing (EUL) procedure assesses the suitability of novel health products during public health emergencies. The main objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency use, while adhering to stringent criteria of safety, efficacy and quality.
The assessment weighs the threat posed by the emergency as well as the benefit that would accrue from the use of the product against any potential risks.
WHO has also listed the Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen and Moderna vaccines for emergency use.
The Brief. Sign up to receive the top stories you need to know right now.